Roche Holding AG
RHHBY | OTC
$55.34
+$1.19 (+2.20%)
At close: Sep 21, 2026, 3:59 PM ET
$55.30
-$0.04 (-0.07%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Revenue | 62.4B | 60.44B | 65.81B | 62.8B | 58.32B | 63.75B |
Cost of Revenue | 16.28B | 15.6B | 18.84B | 19.7B | 16.35B | 17.39B |
Gross Profit | 46.11B | 44.84B | 44.44B | 43.1B | 41.97B | 46.37B |
Operating Income | 13.42B | 15.4B | 17.48B | 17.28B | 18.54B | 21.03B |
Interest Income | 260M | 183M | 67M | 342M | 16M | 99M |
Pretax Income | 11.79B | 14.08B | 16.37B | 17.4B | 17.97B | 16.61B |
Net Income | 8.28B | 11.5B | 12.42B | 13.93B | 14.3B | 13.5B |
Selling & General & Admin | 14.9B | 13.49B | 13.69B | 11.87B | 11.82B | 15.08B |
Research & Development | 15.3B | 14.2B | 15.23B | 14.8B | 13.01B | 12.77B |
Other Expenses | 2.5B | 1.76B | -315M | -854M | -592M | 1.38B |
Operating Expenses | 32.7B | 29.45B | 28.6B | 25.82B | 24.24B | 29.23B |
Interest Expense | 1.4B | 997M | 608M | 419M | 438M | 620M |
Selling & Marketing Expenses | n/a | -1.4B | 9.64B | 9.48B | 9.39B | 10.96B |
Cost & Expenses | 48.98B | 45.05B | 48.34B | 45.52B | 40.59B | 46.62B |
Income Tax Expense | 2.61B | 1.72B | 2.8B | 2.46B | 2.9B | 2.51B |
Shares Outstanding (Basic) | 6.38B | 6.39B | 6.4B | 6.8B | 6.84B | 6.85B |
Shares Outstanding (Diluted) | 6.42B | 6.43B | 6.4B | 6.88B | 6.92B | 6.91B |
EPS (Basic) | 1.30 | 1.80 | 1.94 | 2.05 | 2.09 | 1.97 |
EPS (Diluted) | 1.29 | 1.79 | 1.92 | 2.03 | 2.07 | 1.95 |
EBITDA | 16.62B | 18.41B | 20.8B | 22.19B | 22.97B | 24.97B |
EBIT | 13.2B | 14.94B | 16.98B | 17.74B | 18.4B | 21.03B |
Depreciation & Amortization | 3.42B | 3.46B | 3.82B | 4.45B | 4.57B | 4.31B |
Add to Watchlist
Select watchlists to add or remove RHHBY